Delivery Order SPE2DX22D0049-SPE2D826FA3MB
- Not listed
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,545.12 to AmerSourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, which carries an ultimate completion date of January 13, 2026, operates under a non-competitive set-aside designation and represents a task order against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,204.76 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a non-set-aside, competitively awarded contract with performance occurring in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $12,584.40 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. AmerSourceBergen Drug Corp, headquartered in Conshohocken,...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $33,186 to AmerSourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency Medical Supply Chain awarded a $461,537 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 12, 2026, with a completion date of January 13, 2026. This non-set-aside delivery order was issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2031. The contract involves the delivery of pharmaceutical products and medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a $145,889.10 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-competitive delivery order, issued without set-aside designation, represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,117.20 to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 13, 2026, for completion by January 14, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a task order under AmerSourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency Medical Supply Chain awarded a $141,800.40 delivery order to AmerSourceBergen Drug Corp on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price contract, which carries no set-aside designation, is a child order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,189.08 to AmerSourceBergen Drug Corp on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order is a child contract executed under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The award was made without a set-aside...
- On January 9, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a $20,764.92 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0), headquartered in Conshohocken, Pennsylvania. This non-compete delivery order, set to conclude by January 12, 2026, represents a task order issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent IDC, valued at $999.99 million through December...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA3MBDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $15,992.25 to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-competitive delivery order was issued under AmerSourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 and extending through December 31, 2031. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerSourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, with a proven track record delivering comprehensive pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order represents one of numerous routine transactions executed under the larger IDC vehicle, which enables the company to efficiently supply essential pharmaceutical and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 1/11/26 |